Under this scenario, loss of SHH expression due to hypermethylation leads to the decreased expression of stromal BMP, which in turn stimulates the formation of the basal subtype of human bladder cancer, with poor clinical outcomes. This evidence concerns the gene SHH and urinary bladder carcinoma.